MSC Infusion for Anti-aging and Regenerative Therapy

Inclusion Criteria: 1. All patients \>18yrs old, who are able to read, write and understand Informed Consent form, regarding the experimental nature of this therapy. 2. All Healthy Subjects are eligible for this study 3. Subjects with stable pre-morbid medical conditions, not requiring changes to their current medical therapy for \>6 months prior to enrolling in this study, are eligible. Exclusion Criteria: 1. Uncontrolled blood pressure at the time of enrollment: systolic pressure \>160 mmHg and/or diastolic blood pressure \> 100 mmHg. 2. Having evidence related to renal dysfunction: creatinine \> 1.5 mg/dl or (\>133 mmol/L) for men. creatinine \> 1.4 mg/dl or (\>124 mmol/L) for woman. eGRF \< 40 ml/ min Proteinuria \> 300 mg/day 3. Severe heart disease (NYHA 3/4 or congestive heart failure) 4. Severe liver disease (liver enzymes \>2x baseline, or evidence of coagulopathy) 5. Evidence of ketoacidosis at the time of selection. 6. Evidence of ongoing or frequent hypoglycemia. 7. Severe infection at time of selection 8. Infected with hepatitis B virus or hepatitis C or tuberculosis. 9. Serious allergic constitution 10. Neoplasm detected before/during screening or raised tumour markers CA125 (Females), CA15.3 (Females), CEA, CA19.9, Alpha Fetoprotein (AFP), PSA (Males) 11. Patients who are currently participating in another clinical study involving experimenting drugs and/or medical equipment. 12. Pregnant or Breastfeeding 13. Patients who are unable to perform the tests and assessments needed for the study 14. Patients who do not agree to participate in the study. 15. Patients with pre-morbid medical conditions, who have recently had alterations in their treatment regime (\<6 months).